Company
ChinaRespirent Pharmaceuticals Co., Ltd., China – FDA Inspections
Inspection records and compliance data for Respirent Pharmaceuticals Co., Ltd.. 1 FDA inspection on record, last inspected August 18, 2023.
Company Profile
This profile covers Respirent Pharmaceuticals Co., Ltd. based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 18, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 18, 2023 | Not classified | Human Drugs | 1219606 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Viwit Pharmaceutical Co., Ltd.
Hainan Simcere Pharmaceutical Co., Ltd.
Chongqing Pharscin Pharmaceutical Co., Ltd. (Banqiao Road)
Simcere Pharmaceutical Co., Ltd.
Fosun Pharma (Xuzhou) Co., Ltd.
2Y-Biopharma, Ltd.
Zhejiang Yongtai Pharmaceutical Co. Ltd
Bostal Drug Delivery Co., Ltd.
OP NanoPharma Co., Ltd. Yunlin Plant
Company Information
Name
Respirent Pharmaceuticals Co., Ltd.
FEI Number
3015685668
Address
China
Country
China
ID: cb93d48e-159f-4b2f-8c7a-5294475764d0